EnGeneIC vs Gennao Bio
EnGeneIC
First-in-class cyto-immunotherapy platform targeting the tumour directly and leveraging the patient's immune system
60 employees · est. 2001 · Australia
Gennao Bio
A genetic medicines company developing first-in-class, targeted nucleic acid therapeutics
5 employees · est. 2020 · Hopewell, United States
EnGeneIC is the older company (2001 vs 2020); EnGeneIC is the larger of the two.
Side-by-Side Comparison
| Metric | EnGeneIC | Gennao Bio |
|---|---|---|
| Founded | ||
| Founded | 2001 older | 2020 |
| Headquarters | ||
| Headquarters | Australia | Hopewell, United States |
| Employees | ||
| Employees | 60 larger | 5 |
| Industry | ||
| Industry | Biotechnology, Health and Wellness, Life Sciences | Biotechnology, Health Care, Life Sciences |
| Funding Stage | ||
| Funding Stage | Not tracked yet | Series A |
| Total Funding | ||
| Total Funding | $16.08M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 6 | Not tracked yet |
| Services | ||
| Services | research and development of anti-cancer therapies, manufacturing of targeted therapies, clinical trial execution | Not tracked yet |
| Target Customers | ||
| Target Customers | cancer patients, healthcare providers, oncologists, medical researchers, pharmaceutical companies | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Cyto-ImmunotherapyNanocell TechnologyTargeted Drug DeliveryEDV™ PlatformChemotherapeutic DeliveryCancer Therapeutics +9 | Genetic MedicinesNucleic Acid TherapeuticsTargeted TherapeuticsGMAB Platform TechnologyCell-Penetrating AntibodyNon-Viral Delivery System +8 |
| Website | ||
| Website | engeneic.com | gennao.com |
About EnGeneIC
EnGeneIC is an Australian biopharmaceutical startup, established in 2001, that has garnered attention for its innovative approach in the biotechnology sector. The company specializes in the development of its proprietary EDV™ nanocell platform, a groundbreaking technology aimed at improving cancer t...
About Gennao Bio
Gennao Bio is a pioneering force in the realm of genetic medicine, established in 2020. With its focus on developing first-in-class nucleic acid therapeutics, the company sets itself apart through its unique Gene Monoclonal Antibody (GMAB) platform technology. This innovative platform employs a nove...
Also comparing in this category
Comparing more than these two?
Get EnGeneIC, Gennao Bio and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does EnGeneIC compare?
A PDF of EnGeneIC and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare EnGeneIC with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at EnGeneIC on 15 Jun 2026, and Gennao Bio on 28 Jan 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.